Lilly, E
Then, in January 2025, she teamed up with the telehealth company Ro, which her husband, Alexis Ohanian, is an investor in and board member of, to receive Zepbound
We hope that clinicians are encouraged by this study to take a more comprehensive and individual approach to treatment selection, said senior author Yong Chen, PhD, a professor of Biostatistics at Penn
Companies can choose to add these riders to their group plans
Brian Wojeck, MD, MPH, Assistant Professor of Medicine (Endocrinology), Yale School of Medicine, said that because GLP-1 medications treat the primary disease of obesity, they have important effects on obesity-related comorbidities